Phase 2 Depressive Disorder, Treatment-Resistant trials recruiting now

All Depressive Disorder, Treatment-Resistant trials, every phase

Phase 2 Depressive Disorder, Treatment-Resistant trials

• ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
  NCT07284667 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 26 locations
• Intravenous Ketamine for Treatment-Resistant Depression
  NCT06668571 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression
  NCT06511908 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• OSU6162 as add-on in SSRI/SNRI-resistant Depression
  NCT05641623 · Phase: Phase 2 · Ages: 25 Years to 75 Years · Sex: All (male and female) · 4 locations

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.